Aducanumab: The Drug That Breaks Medicare?
Biogen plans to price-gouge for the barely-effective Alzheimer’s drug aducanumab to such a degree that it could bust Medicare.
Read more...Biogen plans to price-gouge for the barely-effective Alzheimer’s drug aducanumab to such a degree that it could bust Medicare.
Read more...The Biden administration should push the WTO to waive COVID vaccine patents before heading off for vacation and encourage U.S. producers to ramp up low-cost vaccine production worldwide.
Read more...The new SEC director of enforcement takes up his post today, the first in this position since 2005 to enter without strong recent corporate ties.
Read more...FTC issues new policy statement announcing a tougher enforcement stance on company repair and warranty practices.
Read more...More worries about Delta.
Read more...Coral reefs are the canary in the coal mine. The collapse of these ecosystems is the first unequivocally tied to climate change.
Read more...An investigation revealing abuse of NSO Group’s Pegasus malware led Snowden to declare: “This is an industry that should not exist.”
Read more...The trauma center ripoff provides more evidence that the medical industry is primarily in the business of exploitation, not care.
Read more...Biden goes after non-compete agreements….but will this effort make a difference?
Read more...The latest Robinhood campaign is more raspberry than rah rah.
Read more...How Bitcoin hard-core loyalists see the future of their project.
Read more...And you believed Biden on climate change?
Read more...Michael Hudson gives another wide-ranging, tour de force interview. Enjoy!
Read more...Last week, President Joe Biden and Apple co-founder Steve Wozniak endorsed the right to repair.
Read more...The opioid crisis provides a deadly example of why innovation often is simply a new-fangled form of predation.
Read more...